Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001586742 | SCV001820599 | likely benign | not provided | 2023-09-13 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Genome Diagnostics Laboratory, |
RCV002276826 | SCV002566187 | likely benign | Ehlers-Danlos syndrome | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458548 | SCV002614567 | benign | Cardiovascular phenotype | 2019-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002501953 | SCV002798057 | likely benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2022-02-07 | criteria provided, single submitter | clinical testing |